Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors

por Piña, Y, Decatur, C, Murray, TG, Houston, SK, Gologorsky, D, Cavalcante, M, Cavalcante, L, Hernandez, E, Celdran, M, Feuer, W, Lampidis, T
Publicado 2011

Lack of Effect of SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2, in a Transgenic Murine Model of Retinoblastoma

por Cebulla, C.M, Jockovich, M.E, Boutrid, H, Piña, Y, Ruggeri, M, Jiao, S, Bhattacharya, S.K, Feuer, W.J, Murray, T.G
Publicado 2008